{"id":"W2005981818","doi":"10.1016/j.clml.2013.12.015","title":"Activity of 129 Single-Agent Drugs in 228 Phase I and II Clinical Trials in Multiple Myeloma","year":2014,"lang":"en","type":"review","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Deutsche Forschungsgemeinschaft; National Cancer Institute; Celgene; Amgen; American Society of Hematology","keywords":"Thalidomide; Medicine; Lenalidomide; Multiple myeloma; Pomalidomide; Oncology; Teniposide; Clinical trial; Bortezomib; Internal medicine; Cyclophosphamide; Melphalan; Pharmacology; Prednisone; Chemotherapy; Etoposide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019586,0.0007760201,0.003526845,0.001787571,0.0001583911,0.001042237,0.0009490923,0.0008684968,0.003362997],"category_scores_gemma":[0.002144972,0.0003659382,0.002344971,0.001990405,0.0003949243,0.0006940603,0.0005074735,0.001332806,0.0004666052],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007260636,"about_ca_system_score_gemma":0.001480357,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001158062,"about_ca_topic_score_gemma":0.003500016,"domain_scores_codex":[0.9995555,0.0001212181,0.0001151498,0.00005671587,0.0001185174,0.00003285896],"domain_scores_gemma":[0.9985557,0.0009425928,0.0002971503,0.00002796151,0.0001217225,0.00005484872],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.002379454,0.0002346265,0.0005441257,0.103245,0.002254074,0.0001412123,0.00008295205,0.0005564293,0.002127999,0.0006864664,0.009165967,0.8785816],"study_design_scores_gemma":[0.01013438,0.01081116,0.01467878,0.07925761,0.03244826,0.002882434,0.0002846095,0.000758157,0.004845197,0.001810665,0.8419158,0.0001729759],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008458281,0.9984348,0.00007253182,0.00009138381,0.00003994213,0.00003263652,0.000060977,0.000006634079,0.0004151627],"genre_scores_gemma":[0.005793544,0.99322,0.0002936668,0.0002735472,0.00004351238,0.00003569479,0.00009748343,0.000002528012,0.0002400821],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003526845,"threshold_uncertainty_score":0.01125032,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2745757903204223,"score_gpt":0.5036168554340602,"score_spread":0.2290410651136379,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}